In a highly anticipated ruling, the Supreme Court finally upheld that specific human genes cannot be patented. This comes at a critical time, as public awareness of the importance of genetic testing of the BRCA1 and BRCA2 genes – genes associated with breast and ovarian cancers—is higher than ever before. Those who may be genetically susceptible to breast and ovarian cancers as well as current cancer patients will now have access to life altering genetic testing at a much lower cost.
GENETICS CENTER is now looking forward to the release of our own BRCA1/2 genetic test, which has been in development. We plan to release this test very shortly. Additionally, we look forward to the future of genetics research, which is no longer restricted by gene patenting, and eagerly anticipate improvement in the quality of medical care available to all patients.